{"id":61734,"date":"2025-08-15T16:06:19","date_gmt":"2025-08-15T14:06:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/"},"modified":"2025-08-15T16:06:19","modified_gmt":"2025-08-15T14:06:19","slug":"u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/","title":{"rendered":"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/report\/united-states-active-pharmaceutical-ingredients-cdmo-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=294bf3&amp;utm_campaign=2082630+-+U.S.+Active+Pharmaceutical+Ingredients+CDMO+Market+Trends+Analysis+Report+2025-2030+%7C+Biologics+Investment%2C+Chronic+Disease+Burden%2C+and+Innovation+Needs+Bolster+Growth&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">&#8220;U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share &amp; Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 &#8211; 2030&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/22\/logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe U.S. active pharmaceutical ingredients CDMO market was valued at USD 25.28 billion in 2024 and is projected to reach USD 33.86 billion by 2030, growing at a CAGR of 5.1% from 2025 to 2030<\/p>\n<p>\nThis report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the U.S. active pharmaceutical ingredients CDMO market report based on product, synthesis, drug, workflow, and application.<\/p>\n<p>\nThis growth is driven by rising demand for advanced pharmaceutical manufacturing services to support the development of innovative drugs and therapies. In addition, increasing investments in biologics and high-potency APIs drive market expansion. The growing prevalence of chronic diseases and the need for efficient, scalable production solutions also contribute to the market&#8217;s momentum.<\/p>\n<p>\nKey drivers supporting this market growth include technological advancements in process chemistry and manufacturing automation, which improve yield, reduce waste, and enhance product quality. Regulatory support encouraging outsourcing to specialized CDMOs is vital, as these organizations help ensure compliance with stringent FDA and international standards.<\/p>\n<p>\nThe increasing focus on personalized medicine and novel therapies drives demand for small-batch, complex API manufacturing, areas where CDMOs excel due to their flexibility and expertise. Growing collaborations between pharmaceutical firms and CDMOs also foster innovation and accelerate time-to-market, enabling companies to meet better evolving patient better needs.<\/p>\n<p>\nThe market presents significant opportunities, especially in developing biologics, gene therapies, and cell therapies requiring highly specialized API manufacturing. The trend toward continuous manufacturing and flow chemistry offers avenues for CDMOs to improve efficiency and scalability while reducing costs and environmental impact.<\/p>\n<p>\n<strong>Why should you buy this report?<\/strong><\/p>\n<ul>\n<li>\nComprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.<\/li>\n<li>\nCompetitive Landscape: Explore the market presence of key players worldwide.<\/li>\n<li>\nFuture Trends: Discover the pivotal trends and drivers shaping the future of the global market.<\/li>\n<li>\nActionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.<\/li>\n<\/ul>\n<p>\n<strong>Companies Featured<\/strong><\/p>\n<ul>\n<li>\nThermo Fisher Scientific Inc.<\/li>\n<li>\nNovo Group (Catalent, Inc.)<\/li>\n<li>\nCambrex Corporation<\/li>\n<li>\nPiramal Pharma Limited<\/li>\n<li>\nCorden Pharma<\/li>\n<li>\nSiegfried Holding AG<\/li>\n<li>\nSeqens North America<\/li>\n<li>\nSK pharmteco Inc.<\/li>\n<li>\nNoramco.<\/li>\n<li>\nBSP Pharmaceuticals<\/li>\n<\/ul>\n<p>\n<strong>Key Attributes:<\/strong><\/p>\n<table>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\"><strong>Report Attribute<\/strong><\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\"><strong>Details<\/strong><\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">No. of Pages<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">80<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">Forecast Period<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">2024 &#8211; 2030<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">Estimated Market Value (USD) in 2024<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">$25.28 Billion<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">Forecasted Market Value (USD) by 2030<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">$33.86 Billion<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-left:solid black 1pt;\">Compound Annual Growth Rate<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;\">5.1%<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\" style=\"border:solid black 1pt;\">Regions Covered<\/td>\n<td colspan=\"1\" rowspan=\"1\" style=\"border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;\">United States\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<p>\n<strong>Chapter 1. Methodology and Scope<\/strong><\/p>\n<p>\n1.1. Market Segmentation and Scope<\/p>\n<p>\n1.2. Market Definition<\/p>\n<p>\n1.3. Information Procurement<\/p>\n<p>\n1.4. Information Analysis<\/p>\n<p>\n1.5. Market Formulation and Data Visualization<\/p>\n<p>\n1.6. Data Validation and Publishing<\/p>\n<p>\n<strong>Chapter 2. Executive Summary<\/strong><\/p>\n<p>\n2.1. Market Snapshot<\/p>\n<p>\n2.2. Segment Snapshot<\/p>\n<p>\n2.3. Competitive Landscape Snapshot<\/p>\n<p>\n<strong>Chapter 3. U.S. Active Pharmaceutical Ingredients CDMO Market Variables, Trends and Scope<\/strong><\/p>\n<p>\n3.1. Market Lineage Outlook<\/p>\n<p>\n3.2. Market Dynamics<\/p>\n<p>\n3.2.1. Market Driver Analysis<\/p>\n<p>\n3.2.2. Market Restraint Analysis<\/p>\n<p>\n3.2.3. Industry Challenge<\/p>\n<p>\n3.3. Industry Analysis Tools<\/p>\n<p>\n3.3.1. Porter&#8217;s Analysis<\/p>\n<p>\n3.3.2. PESTEL Analysis<\/p>\n<p>\n<strong>Chapter 4. U.S. Active Pharmaceutical Ingredients CDMO Market: Product Estimates and Trend Analysis<\/strong><\/p>\n<p>\n4.1. U.S. Active Pharmaceutical Ingredients CDMO Market, By Product: Key Takeaways<\/p>\n<p>\n4.2. Product Movement Analysis and Market Share, 2024 and 2030<\/p>\n<p>\n4.3. Market Estimates and Forecasts, By Product, 2018 &#8211; 2030 (USD Million)<\/p>\n<p>\n4.3.1. Traditional Active Pharmaceutical Ingredient<\/p>\n<p>\n4.3.1.1. Market Revenue Estimates and Forecasts, 2018 &#8211; 2030 (USD Million)<\/p>\n<p>\n4.3.2. Highly Potent Active Pharmaceutical Ingredient<\/p>\n<p>\n4.3.3. Antibody Drug Conjugate (ADC)<\/p>\n<p>\n4.3.4. Other<\/p>\n<p>\n<strong>Chapter 5. U.S. Active Pharmaceutical Ingredients CDMO Market: Synthesis Estimates and Trend Analysis<\/strong><\/p>\n<p>\n5.1. U.S. Active Pharmaceutical Ingredients CDMO Market, By Synthesis: Key Takeaways<\/p>\n<p>\n5.2. Synthesis Movement Analysis and Market Share, 2024 and 2030<\/p>\n<p>\n5.3. Market Estimates and Forecasts, By Synthesis, 2018 &#8211; 2030 (USD Million)<\/p>\n<p>\n5.3.1. Synthetic<\/p>\n<p>\n5.3.2. Biotech<\/p>\n<p>\n<strong>Chapter 6. U.S. Active Pharmaceutical Ingredients CDMO Market: Drug Estimates and Trend Analysis<\/strong><\/p>\n<p>\n6.1. U.S. Active Pharmaceutical Ingredients CDMO Market, By Drug: Key Takeaways<\/p>\n<p>\n6.2. Drug Movement Analysis and Market Share, 2024 and 2030<\/p>\n<p>\n6.3. Market Estimates and Forecasts, By Drug, 2018 &#8211; 2030 (USD Million)<\/p>\n<p>\n6.3.1. Innovative<\/p>\n<p>\n6.3.2. Generic<\/p>\n<p>\n<strong>Chapter 7. U.S. Active Pharmaceutical Ingredients CDMO Market: Workflow Estimates and Trend Analysis<\/strong><\/p>\n<p>\n7.1. U.S. Active Pharmaceutical Ingredients CDMO Market, By Workflow: Key Takeaways<\/p>\n<p>\n7.2. Workflow Movement Analysis and Market Share, 2024 and 2030<\/p>\n<p>\n7.3. Market Estimates and Forecasts, By Workflow, 2018 &#8211; 2030 (USD Million)<\/p>\n<p>\n7.3.1. Clinical<\/p>\n<p>\n7.3.2. Commercial<\/p>\n<p>\n<strong>Chapter 8. U.S. Active Pharmaceutical Ingredients CDMO Market: Application Estimates and Trend Analysis<\/strong><\/p>\n<p>\n8.1. U.S. Active Pharmaceutical Ingredients CDMO Market, By Application: Key Takeaways<\/p>\n<p>\n8.2. Application Movement Analysis and Market Share, 2024 and 2030<\/p>\n<p>\n8.3. Market Estimates and Forecasts, By Application, 2018 &#8211; 2030 (USD Million)<\/p>\n<p>\n8.3.1. Oncology<\/p>\n<p>\n8.3.2. Hormonal<\/p>\n<p>\n8.3.3. Glaucoma<\/p>\n<p>\n8.3.4. Cardiovascular disease<\/p>\n<p>\n8.3.5. Diabetes<\/p>\n<p>\n8.3.6. Others<\/p>\n<p>\n<strong>Chapter 9. Competitive Landscape<\/strong><\/p>\n<p>\n9.1. Company Categorization<\/p>\n<p>\n9.2. Company Market Positioning<\/p>\n<p>\n9.3. Company Heat Map Analysis<\/p>\n<p>\n9.4. Company Profiles<\/p>\n<p>\n9.4.1. Company Overview<\/p>\n<p>\n9.4.2. Financial Performance<\/p>\n<p>\n9.4.3. Product Portfolio<\/p>\n<p>\n9.4.4. Recent Developments\/ Strategic Initiatives<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/report\/united-states-active-pharmaceutical-ingredients-cdmo-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=294bf3&amp;utm_campaign=2082630+-+U.S.+Active+Pharmaceutical+Ingredients+CDMO+Market+Trends+Analysis+Report+2025-2030+%7C+Biologics+Investment%2C+Chronic+Disease+Burden%2C+and+Innovation+Needs+Bolster+Growth&amp;utm_exec=chdomspi\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/heobjn<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;&#114;&#x65;&#115;&#x73;&#64;&#x72;&#101;&#x73;&#101;&#x61;&#114;&#x63;&#104;&#x61;&#110;&#x64;&#109;&#x61;r&#x6b;e&#x74;s&#x2e;c&#x6f;m\" rel=\"nofollow\" shape=\"rect\">&#112;&#x72;e&#x73;s&#64;&#x72;&#101;&#x73;e&#97;&#x72;&#99;&#x68;a&#x6e;&#x64;&#109;&#x61;r&#x6b;e&#116;&#x73;&#46;&#x63;o&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share &amp; Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The U.S. active pharmaceutical ingredients CDMO market was valued at USD 25.28 billion in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61734","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share &amp; Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The U.S. active pharmaceutical ingredients CDMO market was valued at USD 25.28 billion in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-15T14:06:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/22\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2025-08-15T14:06:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/\"},\"wordCount\":876,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250815360481\\\/en\\\/2554529\\\/22\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/\",\"name\":\"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250815360481\\\/en\\\/2554529\\\/22\\\/logo.jpg\",\"datePublished\":\"2025-08-15T14:06:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250815360481\\\/en\\\/2554529\\\/22\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250815360481\\\/en\\\/2554529\\\/22\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share &amp; Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The U.S. active pharmaceutical ingredients CDMO market was valued at USD 25.28 billion in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-15T14:06:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/22\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth &#8211; ResearchAndMarkets.com","datePublished":"2025-08-15T14:06:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/"},"wordCount":876,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/22\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/","name":"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/22\/logo.jpg","datePublished":"2025-08-15T14:06:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/22\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250815360481\/en\/2554529\/22\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/u-s-active-pharmaceutical-ingredients-cdmo-market-trends-analysis-report-2025-2030-biologics-investment-chronic-disease-burden-and-innovation-needs-bolster-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"U.S. Active Pharmaceutical Ingredients CDMO Market Trends Analysis Report 2025-2030 | Biologics Investment, Chronic Disease Burden, and Innovation Needs Bolster Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61734"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61734\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}